NeoGram Derivatized Assay Solutions - The product is to be used together with the - Wallac Oy

Duns Number:540156544

Device Description: The product is to be used together with the NeoGram Amino Acids and Acylcarnitines Tandem The product is to be used together with the NeoGram Amino Acids and Acylcarnitines Tandem Mass Spectrometry kit, and is intended for the measurement of amino acid, free carnitine, and acylcarnitine concentrations from newborn heel prick blood samples dried on filter paper.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

3030-0020

Brand Name

NeoGram Derivatized Assay Solutions

Version/Model Number

3030-0020

Device Commercial Distribution Status

Not in Commercial Distribution

Commercial Distribution End Date

March 18, 2022

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

-

Prescription Use (Rx)

-

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

DEN040002

Product Code Details

Product Code

NQL

Product Code Name

System, Test, Amino Acids, Free Carnitines And Acylcarnitines Tandem Mass Spectrometry

Device Record Status

Public Device Record Key

942d8fcf-a3cc-431c-b8e1-ae801d719cc2

Public Version Date

March 30, 2022

Public Version Number

4

DI Record Publish Date

February 11, 2016

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"WALLAC OY" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 57
2 A medical device with a moderate to high risk that requires special controls. 38
3 A medical device with high risk that requires premarket approval 2